Autoimmune hepatitis: From the clinic to the diagnostics laboratory

Laboratory Medicine

Volumn 42, Issue 4, 2011, Pages 224-233

  Mackay, Ian R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Actin microfilaments; Antinuclear antibody; Autoimmune hepatitis; Hypergamma globulinemia; Immunofluorescence; Liver kidney microsomal antibody

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; DOUBLE STRANDED DNA ANTIBODY; LIVER CYTOSOLIC ANTIGEN 1; LIVER KIDNEY MICROSOMAL AUTOANTIGEN; LIVER PANCREAS ANTIGEN; SMOOTH MUSCLE AUTOANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; CLINICAL FEATURE; CLINICAL LABORATORY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LIVER MICROSOME; NONHUMAN; SCORING SYSTEM; SEROLOGY;

EID: 79955526001     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM7EUBRRUPLF9V6R     Document Type: Article

References (59)

1. Mackay IR. Historical reflections on autoimmune hepatitis. World J Gastroenterol. 2008;14:3292-3300.
2. Himsworth HP. Lectures on the Liver and its Diseases. Oxford, England: Blackwell; 1947:158-161.
3. MacDonald RA, Mallory GK. The natural history of postnecrotic cirrhosis: A study of 221 autopsy cases. Am J Med. 1958;24:334-357.
4. Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet. 1965;2:878-879.
5. Whittingham S, Irwin J, Mackay IR, et al. Smooth muscle autoantibody in "autoimmune" hepatitis. Gastroenterology. 1966;51:499-505.
6. Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sci. 1965;124:767-780.
7. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998-1005.
8. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
9. Searle J, Harmon BV, Bishop CJ, et al. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol. 1987;2:77-96.
10. Page AR, Good RA. Plasma cell hepatitis, with special attention to steroid therapy. AMA J Dis Child. 1960:99:288-314.
11. Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677-683.
12. Bogdanos DP, Invernizzi P, Mackay IR, et al. Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol. 2008;14:3374-3387.
13. Cançado EL, Abrantes-Lemos CP, Vilas-Boas LS, et al. Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection. J Autoimmun. 2001;17:223-228.
14. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997;40:1601-1611.
15. Mackay IR. Autoimmune diseases of the liver. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases. Orlando, FL: Academic Press; 1985:291-337.
16. Czaja AJ, Nishioka M, Morshed SA, et al. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology. 1994;107:200-207.
17. Smeenk R, van der Lelij G, Swaak T, et al. Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay. Arthritis Rheum. 1982;25:631-638.
18. Leggett BA, Collins RV, Cooksley WGE, et al. Evaluation of the crithidia assay to distinguish between chronic active hepatitis and systemic lupus erythematosus. J Gastroenterol Hepatol. 1987;2:202-211.
19. Smalley MJ, Mackay IR, Whittingham S. Antinuclear factors and human leucocytes: Reaction with granulocytes and lymphocytes. Australas Ann Med. 1968;17:28-32.
20. Zauli D, Ghetti S, Grassi A, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis. Hepatology. 1997;25:1105-1107.
21. Terjung B, Worman HJ, Herzog V, et al. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol. 2001;126:37-46.
22. Whittingham S, Irwin J, Mackay IR, et al. Smooth muscle autoantibody in "autoimmune" hepatitis. Gastroenterology. 1966;51:499-505.
23. Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996;24:1068-1073.
24. Bottazzo GF, Florin-Christensen A, Fairfax A, et al. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976;29:403-410.
25. Gabbiani G, Ryan GB, Lamelin JP, et al. Human smooth muscle autoantibody: Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol. 1973;72:473-488.
26. Lidman K, Biberfeld G, Fagraeus A, et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol. 1976;24:266-272.
27. Watanabe S, Miyazaki A, Hirose M, et al. Myosin in hepatocytes is essential for bile canalicular contraction. Liver. 1991;11:185-189.
28. Toh BH, Taylor R, Pollock W, et al. "Actin-reactive" discriminated from "non-actin-reactive" smooth muscle autoantibody by immunofluorescence reactivity with rat epithelial cell line. Pathology. 2010;42:463-469.
29. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979;38:621-628.
30. Pollard TD, Cooper JA. Actin, a central player in cell shape and movement. Science. 2009;326:1208-1212.
31. Mackay IR, Martinez-Neira R, Whittingham S, et al. Autoantigenicity of actin. In: dos Remedios C, Chhabra D, eds. Actin, Actin-binding Proteins and Disease. New York, NY: Springer; 2008:50-64.
32. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 2000;32:181-197.
33. Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet. 2000;355:1510-1515.
34. Kernebeck T, Lohse AW, Grötzinger J. A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology. 2001;34:230-233.
35. Herkel J, Manns MP, Lohse AW. Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis. Hepatology. 2007;46;275-277.
36. Rizzetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973;15:331-344.
37. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis with antiliver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology. 1987;7:1333-1339.
38. Manns MP, Johnson EF, Griffin KJ, et al. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest. 1989;83:1066-1072.
39. Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988;8:1662-1666.
40. Muratori L, Cataleta M, Muratori P, et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: Comparison of different techniques. J Immunol Methods. 1995;187:259-264.
41. Lapierre P, Johanet C, Alvarez F. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Eur J Immunol. 2003;33:1869-1878.
42. Chisari FV. Liver-specific protein in perspective. Gastroenterology. 1980;78:168-170.
43. McFarlane IG, McFarlane BM, Major GN, et al. Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984;55:347-354.
44. Treichel U, McFarlane BM, Seki T, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 1994;107:799-804.
45. Schreiter T, Liu C, Gerken G, et al. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1. J Immunol Methods. 2005;301:1-10.
46. Swanson NR, Reed WD, Yarred LJ, et al. Autoantibodies to isolated plasma membranes in chronic active hepatitis II: Specificity of antibodies. Hepatology. 1990;11:613-621.
47. Matsuo I, Ikuno N, Omagari K, et al. Autoimmune reactivity of sera to hepatocyte plasma membrane in type 1 autoimmune hepatitis. J Gastroenterol. 2000;35:226-234.
48. Tahiri F, Le Naour F, Huguet S, et al. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology. 2008;47:937-948.
49. Hennes EM, Zeniya M, Czaja A, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169-176.
50. Czaja A. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540-1548.
51. Mackay IR. Clustering and commonalities among autoimmune diseases. J Autoimmun. 2009;33:170-177.
52. Mieli-Vergani G, Heller S, Jara P, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158-164.
53. O'Brien C, Joshi S, Feld JJ, et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology. 2008;48:550-556.
54. Mackay IR. The etiopathogenesis of autoimmunity. Semin Liver Dis. 2005;25:239-250.
55. Longhi MS, Ma Y, Mieli-Vergani G, et al. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010;34:7-14.
56. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: Important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004;1:2.
57. Storch WB. Autoimmune hepatitides-update 2004. Cell Mol Biol (Noisyle-grand). 2004;50. Online Pub:OL569-80.
58. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54-66.
59. Nimmo MC. Autoimmune hepatitis: A brief review with an emphasis on autoimmune testing. LabMed. 2007;38:248-251.